Louisiana 2013 Regular Session

Louisiana House Bill HB499

Introduced
4/8/13  
Introduced
4/8/13  
Refer
4/8/13  

Caption

Requires state agencies which administer tax credits and rebates to annually report certain information (OR NO IMPACT GF EX See Note)

Impact

The enactment of HB 499 will likely affect how state agencies evaluate and report on tax incentives, which are crucial for economic development initiatives. It will compel these agencies to conduct a thorough review of their tax incentive programs, assess their efficiency, and report findings to the legislature. This change aims to ensure that state resources are managed responsibly and that tax incentives effectively contribute to economic growth without unintentionally causing revenue losses for the state.

Summary

House Bill 499 mandates that state agencies responsible for administering tax credits and rebates must submit an annual report to the legislature detailing the performance and impact of these tax incentives. This report, due by March 1 each year, must include assessments of whether each incentive has met its intended purpose, provided a positive return on investment for the state, and any unintentional outcomes resulting from the incentives. The bill emphasizes accountability and transparency in the allocation and administration of tax incentives within the state.

Sentiment

The sentiment around HB 499 appears to be supportive, particularly among those advocating for greater transparency and accountability in government spending. Stakeholders and legislators who believe in fiscal responsibility applaud the efforts to systematically assess tax incentives. However, there may also be concerns regarding the compliance burden placed on state agencies and the potential for a reduction in incentive programs if they do not yield clear benefits, which could lead to debates over the balance between incentivizing growth and managing public funds.

Contention

Notable points of contention surrounding HB 499 may stem from the interpretation of what constitutes a 'successful' tax incentive. There could be disagreements regarding the criteria set forth for evaluation, especially how success is measured and the potential implications for agencies. Some may argue that stringent reporting requirements could discourage the use of tax incentives, thus hampering economic development initiatives meant to help specific sectors or communities. The law's details on confidentiality for proprietary information may also lead to disputes over transparency versus business privacy.

Companion Bills

No companion bills found.

Previously Filed As

LA HB316

Requires state agencies which administer tax credits and rebates to report certain information (EN NO IMPACT GF EX See Note)

LA HB1104

Requires state agencies which administer tax credits to report certain information (EN NO IMPACT GF EX See Note)

LA HB342

Changes the deadline for agencies which administer tax incentives to submit reports to the legislature (EN +$110,000 GF EX See Note)

LA HB1119

Changes the deadline for submission of reports by agencies which administer certain tax incentives and authorizes electronic submission of such reports (EG INCREASE GF EX See Note)

LA HB805

Requires the Department of Revenue to annually report certain tax expenditure information (OR NO IMPACT GF EX See Note)

LA SB373

Provides for the required reporting of certain revenue, exemptions, credits, rebates in the tax exemption budget and on LaTrac. (8/1/18) (EN NO IMPACT See Note)

LA HB535

Requires the Louisiana Legislative Auditor to evaluate state tax incentives (EN +$43,000 GF EX See Note)

LA HB587

Requires the termination of certain tax credits (OR SEE FISC NOTE GF RV See Note)

LA HB1251

Requires the annual reporting of certain information relative to capital outlay projects (EN NO IMPACT GF EX See Note)

LA SB79

Provides relative to expenditures utilized to claim income and franchise tax credits. (gov sig) (EG SEE FISC NOTE GF RV See Note)

Similar Bills

RI S2086

Prohibits healthcare entities from interfering with a patient's right to choose to obtain a clinician-administered drug from their provider or pharmacy of choice.

RI S0870

Accident And Sickness Insurance Policies

RI H7365

Provides that health insurers provide coverage for covered clinician-administered drugs under certain circumstances.

RI H5680

Accident And Sickness Insurance Policies

NJ A797

Limits upfront costs for oral anticancer medications for persons covered under certain health benefits plans.

NJ A2464

Limits upfront costs for oral anticancer medications for persons covered under certain health benefits plans.

RI H8254

Accident And Sickness Insurance Policies

CA AB590

State-funded assistance grants and contracts: advance payments.